3 hours ago · New York
FTC: ‘Pharma bro’ Shkreli violated lifetime industry ban, should be held in contempt
What's happening
SignalsMonitor is following this as a markets story. The Hill is the outlet attached so far. The reports are tied to New York. The first report grouped here was at 13 Oct 2026, 17:05 UTC. The headline in use is “FTC: ‘Pharma bro’ Shkreli violated lifetime industry ban, should be held in contempt”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
The Federal Trade Commission (FTC) and a coalition of seven states asked a federal court on Tuesday to punish Martin Shkreli for “flagrantly and repeatedly” violating a lifetime ban from being involved in the pharmaceutical industry. In a court filing in the U.
Related topics and places
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by The Hill
FTC: ‘Pharma bro’ Shkreli violated lifetime industry ban, should be held in contempt
Reported by 1 outlet
- The Hill